Navigation Links
Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A

Chloe Etienne, Allan Gandy, Diana Davis, and Aiguo Zhang, Bio-Rad Laboratories, Inc., 2000 Alfred Nobel Drive, Hercules, CA 94547 USA

The Bio-Plex suspension array system is an integrated system consisting of hardware, software, and assay kits. The system employs bead-based Luminex technology to simultaneously analyze up to 100 targets in a single microplate well. The Bio-Plex validation kit is a tool designed for operational qualification of the system. The kit validates the performance of the fluidics and optics systems, the two primary components of the suspension array reader. A high correlation exists between the validation kit parameters and assay performance; therefore, proper validation of the system is essential for ensuring optimal assay performance. In this technical study, the optics system of a reader was deliberately misaligned to varying degrees to demonstrate the effect of a poorly maintained system on assay performance. At varying degrees of misalignment, reporter channel performance was evaluated using the Bio-Plex validation kit. The effect of misaligned optics was further illustrated by analyzing a 3-plex cytokine assay at each degree of system misalignment.

Validation Kit Parameters
Qualification of analytical instruments is a formal process of documenting that an instrument is fit for its intended use and that it is kept maintained and calibrated (Bedson and Sargent 1996). The Bio-Plex validation kit is used for operational qualification of the Bio-Plex suspension array system. The validation kit consists of four sets of beads that are used to evaluate the performance parameters listed in Table 1.

The reporter validation test is designed to confirm that the reporter channel is correctly measuring assay signals by simulating the results of a typical assay. This test utilizes a set of beads containing various intensities of a dye similar to R-phycoerythrin, the fluorochrome used in Bio-Plex assays.*

The fluorescence of each bead within the set is expressed as molecules of equivalent soluble fluorescence, or MESF, a unit that corresponds to the fluorescence intensity of a given number of pure fluorochrome molecules in solution (Henderson et al. 1998). The beads are analyzed on the Bio-Plex system and a plot of fluorescence intensity versus concentration is created. The plot is used to calculate a series of parameters that are typically used to evaluate assay performance, including dynamic range, accuracy, linearity, sensitivity, and slope. Table 2 lists each of the parameters and their respective definitions.

Methods and Results
Effect of Misaligned Optics on Reporter Channel Performance
If the Bio-Plex system is moved or jarred, its optics may become misaligned, adversely affecting assay results. To demonstrate this phenomenon, the optics path of the reporter channel of a Bio-Plex system was deliberately misaligned to different degrees. The degree of misalignment of the system was verified using the reporter channel %CV of the optics validation test (7.6%, 10.5%, 16.0%, and 18.0%). A reporter channel %CV of <10% is considered acceptable. At each degree of misalignment, a reporter validation test was performed and each of the reporter validation parameters (dynamic range, linearity, accuracy, slope, and sensitivity) was evaluated to assess the ef fect of optics misalignment on reporter channel performance, as shown in Table 3. In each case where the optics validation test fell outside acceptable specifications, certain parameters of the reporter validation test also showed unacceptable results. The slope decreased when the reporter %CV increased to 16%. When the slope decreased, the dynamic range also decreased. Sensitivity was significantly reduced at a reporter %CV of 16%. The accuracy was affected most significantly, with a value outside of acceptable specifications when the reporter %CV was >10.5%. These data indicate a high correlation between optics alignment and reporter channel performance.

Effect of Misaligned Optics on Cytokine Assay Performance
The effect of misaligned optics was also analyzed using a 3-plex cytokine assay (IL-6, IL-8, and GM-CSF) on a system at varying degrees of misalignment. The same parameters measured in the reporter validation kit were also evaluated for actual assays, including sensitivity, slope, and dynamic range. More specifically, five parameters were evaluated: 1) limit of detection (LOD) as defined by 3 standard deviations (SD) above the mean of the background, 2) low fluorescence intensity signal (equal to background), 3) high fluorescence intensity signal (10,000 pg/ml standard concentration), 4) dynamic range of the standard curve, and 5) signal-to-noise ratio of the 3.9 pg/ml standard. The results of the analyses of the three cytokines are shown in Table 4. When the optics alignment and reporter validation values fell outside acceptable specifications, the assay parameters changed significantly (Table 3). The signal-to-noise ratio and dynamic range were affected, while the LOD rem ained constant for two of the three cytokines. As the instrument was misaligned to a greater degree (that is, the reporter %CV increased), the overall signal of the assay decreased across the entire standard curve. This is evident when comparing the low and high assay signals for all three cytokines. For example, the IL-6 assay showed a reduction in relative fluorescence intensity of the 10,000 pg/ml standard from 26,060 to 3,698 when the instrument was misaligned to a reporter channel %CV of 18%. As the overall signal of the assay decreased, the slope decreased significantly and the dynamic range of the assay also decreased. These parameters indicate that assay performance is significantly negatively affected by misalignment of the optics.


The effects of misalignment on assay performance are further shown when comparing the standard curves from each of the three cytokines (see figure). The standard curve for all three cytokines was shifted downward even when the reporter %CV was shifted from 7.6% to 10.5%.

A number of conclusions may be drawn from this study. When a system is misaligned and the optics validation is affected (as determined by the optics validation reporter %CV), reporter validation parameters are also affected, indicating a high correlation between the optics and reporter validation parameters. The performance of a cytokine assay is affected in the same manner as the reporter validation kit parameters, indicating that the validation kit parameters correlate with cytokine assay performance. Finally, cytokine assay performance parameters are directly affected by the alignment of the optics, indicating that proper validation of the system is critical. Overall, these data suggest that the Bio-Plex validation kit is an essential tool for validating the performance of the Bio-Plex system, thereby ensuring optimal assay performance.

Bedson P and Sargent M, The development and application of guidance on equipment qualification of analytical instruments, Accred Qual Assur 1, 265274 (1996)

Henderson LO et al., Terminology and nomenclature for standardization in quantitative fluorescence cytometry, Cytometry 33, 97105 (1998)

Luminex is a trademark of Luminex Corporation. The Bio-Plex suspension array system includes fluorescently labeled microspheres and instrumentation licensed to Bio-Rad Laboratories, Inc. by the Luminex Corporation.

* The terms fluorophore, fluorochrome, and fluorescent dye are used interchangeably.

back to top


Page: All 1 2 3 4 5

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
3. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
4. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
5. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
6. Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays
7. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
8. Human Universal cDNA Library Array I
9. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
10. aRNA Synthesis and Labeling for Array Analysis
11. ArrayScript RT: Maximize Yields of Full-length cDNA
Post Your Comments:

(Date:5/24/2017)... ... May 24, 2017 , ... Today, the South Davis ... Advanced Biological Nutrient Recovery (ABNRâ„¢) technology at its 4,000,000 gallon per day South ... to sustainably meet current and future nutrient discharge regulations. The ABNR platform, which ...
(Date:5/24/2017)... Ebola resurfaces in the Democratic Republic of Congo ... reported, a new analysis of the Ebola gene polymerase Replikin ... 2014 and 2017 outbreaks of the disease.  ... the 2014 outbreak. An analysis of the latest data showed ... which again precedes the current outbreak in the DRC. Sequence ...
(Date:5/23/2017)... ... 2017 , ... Genedata, a leading provider of advanced software ... a strong presence at Bio-IT World Conference & Expo 2017 in Boston, MA. ... all attendees to view posters on the entire range of Genedata software ...
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, ... announced a facility expansion to accommodate its rapid growth. , The renovations at ... and renovation of the existing areas. The expansion includes, a state-of-the-art engineering facility, ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
Breaking Biology News(10 mins):